Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011872
Filing Date
2018-05-08
Accepted
2018-05-08 16:32:22
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vsar-10q_20180331.htm 10-Q 1134268
2 EX-31.1 vsar-ex311_8.htm EX-31.1 16929
3 EX-32.1 vsar-ex321_6.htm EX-32.1 4177
  Complete submission text file 0001564590-18-011872.txt   3421749

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vsar-20180331.xml EX-101.INS 602758
5 XBRL TAXONOMY EXTENSION SCHEMA vsar-20180331.xsd EX-101.SCH 29726
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20180331_cal.xml EX-101.CAL 30179
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20180331_def.xml EX-101.DEF 61760
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20180331_lab.xml EX-101.LAB 204689
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20180331_pre.xml EX-101.PRE 147757
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 18815132
SIC: 2834 Pharmaceutical Preparations